Head Office Novartis International AG CH-4002 Basel Switzerland
+41 61 324 11 11 +41 61 324 80 01 Monday - Friday, 8:30 - 17:00, GMT+1 (Central European Time)
More information
Novartis International AG Investor Relations P.O. Box CH-4002 Basel Switzerland
+41 61 324 79 44 investor.relations@novartis.com
Global Media Relations Eric Althoff Basel, Switzerland
+41 61 324 7999 eric.althoff@novartis.com
Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.
Reporting side effects
Download or order key corporate publications using the tabs below. The Annual Report and 20-F contain our complete audited financial statements.
Please fill in all mandatory fields marked with an asterisk (*)
US residents can order the Annual Report 2012 and the Form 20-F 2012 by following this link
Personal data marked with an asterisk (*) are essential to provide our service to you and must be filled out.
Back to top
Annual Report 2012
Clinical pipeline
Executive Committee
Novartis Media Center
Annual Results Conference media release (302 KB)
Corporate organizational structure (41 KB)
Novartis campus brochure (486 KB)
Stock performance
Annual report 2012 >